Exact Mass: 515.2519
Exact Mass Matches: 515.2519
Found 500 metabolites which its exact mass value is equals to given mass value 515.2519
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Candoxatril
Candoxatril is only found in individuals that have used or taken this drug. It is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of candoxatrilat (UK-69578), a potent neutral endopeptidase (NEP) inhibitor used in the treatment of chronic heart failure.Neutral endopeptidase inhibitors such as Candoxatril have a dual mechanism of action. They inhibit two metalloprotease enzymes, neutral endopeptidase and ACE, resulting in an increased availability of natriuretic peptides that exhibit vasodilatory effects and, possibly, tissue protective effects. D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Alpha-Trisaccharide
The trisaccharides A and B are practically identical from the conformational point of view, the only difference being situated at position 2 of Galalpha residue, i.e. trisaccharide A has a NHAc group, whereas trisaccharide B has a hydroxyl group (PMID: 16133833). Alpha-Trisaccharide is expressed in intestinal mucosa. The trisaccharides A and B are practically identical from the conformational point of view, the only difference being situated at position 2 of Galalpha residue, i.e. trisaccharide A has a NHAc group, whereas trisaccharide B has a hydroxyl group.(PMID: 16133833)
Enzastaurin
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
Perphenazine enanthate
3-(1-((4-Carboxycyclohexyl)carbamoyl)cyclopentyl)-2-(2-methoxyethoxymethyl)propanoic acid 5-indanyl ester
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
2-[(3R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid
C28H37NO8_Pentanedioic acid, 2-[(6S,8aS)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxospiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalen]-7(3H)-yl]
C28H37NO8_2-{2-[(3E)-4,8-Dimethyl-3,7-nonadien-1-yl]-3,5-dihydroxy-2-methyl-7-oxo-3,4,7,9-tetrahydropyrano[2,3-e]isoindol-8(2H)-yl}pentanedioic acid
C25H33N5O7_2-({3-Phenyl-3-[(N-{2-[(1H-pyrrol-2-ylcarbonyl)amino]butanoyl}seryl)amino]propanoyl}amino)butanoic acid
C28H37NO8_2-[(6R,8aS)-4,6-Dihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-7(3H)-yl]pentanedioic acid
C28H37NO8_Pentanedioic acid, 2-[(2R,2R,6R,8aS)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxospiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalen]-7(3H)-yl]-, (2S)
(2S)-2-[(3R,7R,8R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid
candoxatril
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9663; ORIGINAL_PRECURSOR_SCAN_NO 9662 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9679; ORIGINAL_PRECURSOR_SCAN_NO 9676 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9678; ORIGINAL_PRECURSOR_SCAN_NO 9675 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9724; ORIGINAL_PRECURSOR_SCAN_NO 9721 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9734; ORIGINAL_PRECURSOR_SCAN_NO 9733 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9729; ORIGINAL_PRECURSOR_SCAN_NO 9727
(2S)-2-[(3R,7R,8R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid_major
2-[(3R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid_major
Cys Glu His Lys
Cys Glu Lys His
Cys His Glu Lys
Cys His Lys Glu
Cys His Arg Thr
Cys His Thr Arg
Cys Lys Glu His
Cys Lys His Glu
Cys Arg His Thr
Cys Arg Thr His
Cys Thr His Arg
Cys Thr Arg His
Asp Glu Pro Arg
Asp Glu Arg Pro
Asp Pro Glu Arg
Asp Pro Arg Glu
Asp Pro Val Trp
Asp Pro Trp Val
Asp Arg Glu Pro
Asp Arg Pro Glu
Asp Val Pro Trp
Asp Val Trp Pro
Asp Trp Pro Val
Asp Trp Val Pro
Glu Cys His Lys
Glu Cys Lys His
Glu Asp Pro Arg
Glu Asp Arg Pro
Glu His Cys Lys
Glu His Lys Cys
Glu Lys Cys His
Glu Lys His Cys
Glu Pro Asp Arg
Glu Pro Arg Asp
Glu Arg Asp Pro
Glu Arg Pro Asp
Phe Gly His Arg
Phe Gly Arg His
Phe His Gly Arg
Phe His Asn Val
Phe His Arg Gly
Phe His Val Asn
Phe Asn His Val
Phe Asn Val His
Phe Pro Pro Arg
Phe Pro Arg Pro
Phe Arg Gly His
Phe Arg His Gly
Phe Arg Pro Pro
Phe Val His Asn
Phe Val Asn His
Gly Phe His Arg
Gly Phe Arg His
Gly His Phe Arg
Gly His Arg Phe
Gly Arg Phe His
Gly Arg His Phe
His Cys Glu Lys
His Cys Lys Glu
His Cys Arg Thr
His Cys Thr Arg
His Glu Cys Lys
His Glu Lys Cys
His Phe Gly Arg
His Phe Asn Val
His Phe Arg Gly
His Phe Val Asn
His Gly Phe Arg
His Gly Arg Phe
His Lys Cys Glu
His Lys Glu Cys
His Lys Met Thr
His Lys Thr Met
His Met Lys Thr
His Met Gln Thr
His Met Thr Lys
His Met Thr Gln
His Asn Phe Val
His Asn Val Phe
His Gln Met Thr
His Gln Thr Met
His Arg Cys Thr
His Arg Phe Gly
His Arg Gly Phe
His Arg Thr Cys
His Thr Cys Arg
His Thr Lys Met
His Thr Met Lys
His Thr Met Gln
His Thr Gln Met
His Thr Arg Cys
His Val Phe Asn
His Val Asn Phe
Ile Met Pro Arg
Ile Met Arg Pro
Ile Asn Asn Arg
Ile Asn Arg Asn
Ile Pro Met Arg
Ile Pro Arg Met
Ile Pro Thr Trp
Ile Pro Trp Thr
Ile Gln Gln Gln
Ile Arg Met Pro
Ile Arg Asn Asn
Ile Arg Pro Met
Ile Thr Pro Trp
Ile Thr Trp Pro
Ile Trp Pro Thr
Ile Trp Thr Pro
Lys Cys Glu His
Lys Cys His Glu
Lys Glu Cys His
Lys Glu His Cys
Lys His Cys Glu
Lys His Glu Cys
Lys His Met Thr
Lys His Thr Met
Lys Met His Thr
Lys Met Thr His
Lys Thr His Met
Lys Thr Met His
Leu Met Pro Arg
Leu Met Arg Pro
Leu Asn Asn Arg
Leu Asn Arg Asn
Leu Pro Met Arg
Leu Pro Arg Met
Leu Pro Thr Trp
Leu Pro Trp Thr
Leu Gln Gln Gln
Leu Arg Met Pro
Leu Arg Asn Asn
Leu Arg Pro Met
Leu Thr Pro Trp
Leu Thr Trp Pro
Leu Trp Pro Thr
Leu Trp Thr Pro
Met His Lys Thr
Met His Gln Thr
Met His Thr Lys
Met His Thr Gln
Met Ile Pro Arg
Met Ile Arg Pro
Met Lys His Thr
Met Lys Thr His
Met Leu Pro Arg
Met Leu Arg Pro
Met Pro Ile Arg
Met Pro Leu Arg
Met Pro Arg Ile
Met Pro Arg Leu
Met Gln His Thr
Met Gln Thr His
Met Arg Ile Pro
Met Arg Leu Pro
Met Arg Pro Ile
Met Arg Pro Leu
Met Thr His Lys
Met Thr His Gln
Met Thr Lys His
Met Thr Gln His
Asn Phe His Val
Asn Phe Val His
Asn His Phe Val
Asn His Val Phe
Asn Ile Asn Arg
Asn Ile Arg Asn
Asn Leu Asn Arg
Asn Leu Arg Asn
Asn Asn Ile Arg
Asn Asn Leu Arg
Asn Asn Arg Ile
Asn Asn Arg Leu
Asn Gln Arg Val
Asn Gln Val Arg
Asn Arg Ile Asn
Asn Arg Leu Asn
Asn Arg Asn Ile
Asn Arg Asn Leu
Asn Arg Gln Val
Asn Arg Val Gln
Asn Val Phe His
Asn Val His Phe
Asn Val Gln Arg
Asn Val Arg Gln
Pro Asp Glu Arg
Pro Asp Arg Glu
Pro Asp Val Trp
Pro Asp Trp Val
Pro Glu Asp Arg
Pro Glu Arg Asp
Pro Phe Pro Arg
Pro Phe Arg Pro
Pro Ile Met Arg
Pro Ile Arg Met
Pro Ile Thr Trp
Pro Ile Trp Thr
Pro Leu Met Arg
Pro Leu Arg Met
Pro Leu Thr Trp
Pro Leu Trp Thr
Pro Met Ile Arg
Pro Met Leu Arg
Pro Met Arg Ile
Pro Met Arg Leu
Pro Pro Phe Arg
Pro Pro Arg Phe
Pro Arg Asp Glu
Pro Arg Glu Asp
Pro Arg Phe Pro
Pro Arg Ile Met
Pro Arg Leu Met
Pro Arg Met Ile
Pro Arg Pro Phe
Pro Thr Ile Trp
Pro Thr Leu Trp
Pro Thr Trp Ile
Pro Thr Trp Leu
Pro Val Asp Trp
Pro Val Trp Asp
Pro Trp Asp Val
Pro Trp Ile Thr
Pro Trp Leu Thr
Pro Trp Thr Ile
Pro Trp Thr Leu
Pro Trp Val Asp
Gln His Met Thr
Gln His Thr Met
Gln Ile Gln Gln
Gln Leu Gln Gln
Gln Met His Thr
Gln Met Thr His
Gln Asn Arg Val
Gln Asn Val Arg
Gln Gln Ile Gln
Gln Gln Leu Gln
Gln Gln Gln Ile
Gln Gln Gln Leu
Gln Arg Asn Val
Gln Arg Val Asn
Gln Thr His Met
Gln Thr Met His
Gln Val Asn Arg
Gln Val Arg Asn
Arg Cys His Thr
Arg Cys Thr His
Arg Asp Glu Pro
Arg Asp Pro Glu
Arg Glu Asp Pro
Arg Glu Pro Asp
Arg Phe Gly His
Arg Phe His Gly
Arg Phe Pro Pro
Arg Gly Phe His
Arg Gly His Phe
Arg His Cys Thr
Arg His Phe Gly
Arg His Gly Phe
Arg His Thr Cys
Arg Ile Asn Asn
Arg Leu Asn Asn
Arg Asn Ile Asn
Arg Asn Leu Asn
Arg Asn Asn Ile
Arg Asn Asn Leu
Arg Asn Gln Val
Arg Asn Val Gln
Arg Pro Asp Glu
Arg Pro Glu Asp
Arg Pro Phe Pro
Arg Pro Pro Phe
Arg Gln Asn Val
Arg Gln Val Asn
Arg Thr Cys His
Arg Thr His Cys
Arg Val Asn Gln
Arg Val Gln Asn
Thr Cys His Arg
Thr Cys Arg His
Thr His Cys Arg
Thr His Lys Met
Thr His Met Lys
Thr His Met Gln
Thr His Gln Met
Thr His Arg Cys
Thr Ile Pro Trp
Thr Ile Trp Pro
Thr Lys His Met
Thr Lys Met His
Thr Leu Pro Trp
Thr Leu Trp Pro
Thr Met His Lys
Thr Met His Gln
Thr Met Lys His
Thr Met Gln His
Thr Pro Ile Trp
Thr Pro Leu Trp
Thr Pro Trp Ile
Thr Pro Trp Leu
Thr Gln His Met
Thr Gln Met His
Thr Arg Cys His
Thr Arg His Cys
Thr Trp Ile Pro
Thr Trp Leu Pro
Thr Trp Pro Ile
Thr Trp Pro Leu
Val Asp Pro Trp
Val Asp Trp Pro
Val Phe His Asn
Val Phe Asn His
Val His Phe Asn
Val His Asn Phe
Val Asn Phe His
Val Asn His Phe
Val Asn Gln Arg
Val Asn Arg Gln
Val Pro Asp Trp
Val Pro Trp Asp
Val Gln Asn Arg
Val Gln Arg Asn
Val Arg Asn Gln
Val Arg Gln Asn
Val Trp Asp Pro
Val Trp Pro Asp
Trp Asp Pro Val
Trp Asp Val Pro
Trp Ile Pro Thr
Trp Ile Thr Pro
Trp Leu Pro Thr
Trp Leu Thr Pro
Trp Pro Asp Val
Trp Pro Ile Thr
Trp Pro Leu Thr
Trp Pro Thr Ile
Trp Pro Thr Leu
Trp Pro Val Asp
Trp Thr Ile Pro
Trp Thr Leu Pro
Trp Thr Pro Ile
Trp Thr Pro Leu
Trp Val Asp Pro
Trp Val Pro Asp
a-Trisaccharide
2-((6R,8aS)-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-7(3H)-yl)pentanedioic acid
N,N,N-[(2,4,6,8,8-pentamethylcyclotetrasiloxane-2,4,6-triyl) tris(oxy)]tris[N-ethyl-Ethanamine
diminazene aceturate
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
samarium(3+),1,2,3,5-tetramethylcyclopenta-1,3-diene
Cephalotaxine,3-[4-methyl (2R)-2-hydroxy-2-(3-methylbutyl)butanedioate]
Perphenazine enanthate
Lisavanbulin
D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
Benzenamine, 4,4-((4-(phenylimino)-2,5-cyclohexadien-1-ylidene)methylene)bis(N-phenyl-
2,3,4,5-Tetradehydroprolyl-2-aminobutanoyl-seryl-3-phenyl-beta-alanyl-2-aminobutanoic acid
N5-2,4-diaminobutanoate-N1-citryl-N3-dec-2-enoyl-N3-hydroxy-1,3-diaminopropane
2-[(2S,3S,6R)-6-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-[[(2S)-2-azaniumyl-3-hydroxypropanoyl]amino]-3,6-dihydro-2H-pyran-2-yl]-5-(diaminomethylideneazaniumyl)-2,4-dihydroxypentanoate
2-(4-acetamido-N-[2-(benzotriazol-1-yl)acetyl]anilino)-N-(2-methylbutan-2-yl)-2-(1-methylpyrrol-2-yl)acetamide
1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-[4-[(3-methylphenyl)methoxy]phenyl]methylideneamino]-5-(piperidin-1-ylmethyl)triazole-4-carboxamide
5-(Dodecylamino)-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
N-[(5S,6R,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6S,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6R,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
1-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
N-[(5S,6R,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
1-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
N-[(5R,6S,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6R,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6R,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
4-fluoro-N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
1-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-phenylphenyl)methyl]acetamide
(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(pyridin-4-ylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(5R,6R,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5S,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
4-fluoro-N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
1-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-phenylphenyl)methyl]acetamide
(1S)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(pyridin-4-ylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(2-pyridinylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methylbenzenesulfonamide
[(1S,3R,4R,5R,6R,7S,8R,11S,13R,16R,17R)-6-hydroxy-16-(1-hydroxyethyl)-13-methoxy-5,17,19-trimethyl-14-oxo-2,15-dioxatetracyclo[9.8.0.01,7.03,8]nonadeca-9,18-dien-4-yl] 1H-pyrrole-2-carboxylate
2-amino-3-[hydroxy-[2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]phosphoryl]oxypropanoic acid
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
Enzastaurin
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
all-trans-pentaprenyl diphosphate(3-)
The trianion resulting from the removal of the three protons from the diphosphate group of all-trans-pentaprenyl diphosphate; major species at pH 7.3.
phosphatidylethanolamine 20:4 zwitterion
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 20 carbons and 4 double bonds.
MePC(16:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved